ロード中...
Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis
We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of...
保存先:
主要な著者: | , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2005
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1064885/ https://ncbi.nlm.nih.gov/pubmed/15642147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1457 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|